Press Releases from Biosion.Inc (1 total)
Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of …
Milestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates (ADCs) and reinforces Biosion's "In Global, For Global" collaboration strategy.
NEWARK,…
Go To Page:
